DETECT CHROMOSOMAL ALTERATIONS IN PATIENTS WITH NEUROBLASTOMA USING ARRAY COMPARATIVE GENOMICS HYBRIDIZATION TECHNIQUE
##plugins.themes.vojs.article.main##
Abstract
Neuroblastoma is one of the most common malignancies in children, accounting for about 8% of childhood cancers, ranking 4th after acute leukemia, brain tumors and lymphomas.
Samples: 2 patients with mediastinal tumor detected and diagnosed with neuroblastoma, without MYCN amplication being treated at Center of Children’s Cancer, National Children’s Hospital.
Methods: We used aCGH comparative genomic hybridization technique with 60K resolution.
Results: Two patients had detected genetic mutations of SCA and SCA combined with NCA.
Conclusion: Applying aCGH technique with resolution from 60K can detect genetic changes in neuroblastoma patients. This is the basis for more effective prognosis and treatment of neuroblastoma in the future.
##plugins.themes.vojs.article.details##
Keywords
Neuroblastoma, aCGH, NCA, SCA
References
2. Ambros IM, Brunner B, Aigner G et al. A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma. Clin Cancer Res 2011;17(4):792-804. https://doi.org/10.1158/1078-0432.ccr-10-0830
3. Attiyeh EF, London WB, Mossé YP et al. Chromosome 1p and 11q-dels and outcome in NB. N Engl J Med. 2005; 353:2243–53.https://doi.org/10.1056/nejmoa052399
4. Barr EK, Applebaum MA. Genetic Predisposition to Neuroblastoma. Children (Basel) 2018;5(9):119. https://doi.org/10.3390/children5090119